)
)
Xbrane Biopharma Investor Relations Material
Latest events
Q3 2024
Xbrane Biopharma
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Xbrane Biopharma
Access all reports
Segment Data
Access more data
Revenue by
Source
Outlicensed products
Contract manufacturing
Other
Expenses by
Financials
Xbrane Biopharma is a biotechnology company that develops, manufactures and sells biosimilars worldwide. Many of the company's products are approved to treat cancer patients. Xbrane Biopharma AB (publ) was founded in 2008 and is headquartered in Solna, Sweden.
Key slides for Xbrane Biopharma
Q4 2023
Xbrane Biopharma
Q4 2023
Xbrane Biopharma
Latest articles
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
)
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
XBRANE
Country
🇸🇪 Sweden